Reductions in SOD and CAT have been associated with obesity and metabolic dysfunction [43], which may suggest that, compared with female rats, FR50-treated male rats are more prone to develop metabolic derangement and obesity. This evidence concerns the gene SOD1 and obesity due to melanocortin 4 receptor deficiency.